TE Strecker, Y Zhang, JL Hill, etal Lapatinib, an oral dual inhibitor of ErbB1 and ErbB2, blocks signal transduction pathways and supresses the development of estrogen receptor negative breast cancer Presented at the San Antonio Breast Cancer Symposium December 14 17, 2006 San Antonio, TX abstr 35 Google Scholar 68
buy cialis on line